收藏切换
Standardization of application materials and evidence in the negotiation access system of innovative medicines and medical insurance
收藏切换
Xu-feng MA, Jian-zhou YAN, Rong SHAO
Chinese Journal of New Drugs | 2021, 30(15) : 1361 - 1366
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(15): 1361-1366
Standardization of application materials and evidence in the negotiation access system of innovative medicines and medical insurance
Full
Xu-feng MA, Jian-zhou YAN, Rong SHAO
Affiliations
  • The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, China
Published: 2021-08-15
Outline
收藏切换

This article first sorts out the relevant requirements for application materials and evidence in the practice of China's medical insurance negotiation, and analyzes the problems that exist in China. On this basis, the supporting materials of new drug medical insurance access negotiations in New Zealand, Australia, Canada and other countries were studied in detail. Then we compare China with the above-mentioned countries to analyze the gap between China and these countries in the standardization of application materials and evidence, providing enlightenment and policy recommendations from the experience of New Zealand and other developed countries on China's medical insurance access negotiations, including the preparation of the Chinese version of “Official Guide on Innovative Medicines and Medical Insurance Access”, providing detailed requirements and related templates; optimization of the material framework to form a modular and clear-level supporting material system; strengthening material quality requirements, data source standards and introduction of a self-inspection mechanism.

New Zealand  /  Canada  /  Australia  /  negotiation of medical insurance access  /  innovative drugs  /  application materials  /  evidence
马旭锋, 颜建周, 邵蓉. 创新药品医保谈判准入制度中申报材料和证据的标准化研究. 中国新药杂志, 2021 , 30 (15) : 1361 -1366 .
Xu-feng MA, Jian-zhou YAN, Rong SHAO. Standardization of application materials and evidence in the negotiation access system of innovative medicines and medical insurance[J]. Chinese Journal of New Drugs, 2021 , 30 (15) : 1361 -1366 .
Year 2021 volume 30 Issue 15
23
5
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-28
  • Published:2021-08-15
Article Data
Affiliations
History
  • Accepted:2021-03-30
Funding
Affiliations
    The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT